Block 5: Bone, Calcium Homeostasis and Osteoporosis Flashcards

1
Q

What regulates Ca in blood?

A

Bone, PTH, Vitamin D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

99% of Ca2+ is found in?

A

Hydroxypatite crystals in bone

Free, ionized Ca2+ is active

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the importance of phosphorous?

A

Essensial for bone, ATP, cAMP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What components co-regulates Ca2+ and Phosphorous?

A

1, 25-dihydroxycholecalciferol increases Ca2+ absorption
PTH increases calcium absorption and decreases plasma phosphate in kidneys
Fibroblast growth factor-23 (FGF23) inhibits renal phosphate reabsorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Falling blood Ca2+ levels signal ___, while Rising blood Ca2+ levels trigger ____?

A

Falling blood Ca2+ levels signal the parathyroid glands to release PTH degrading bone matrix

Rising blood Ca2+ levels trigger the thyroid to release calcitonin that deposits calcium salts in bone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are cells of a parathyroid gland?

A

Chief cells: Secretes parathyroid hormone
Oxyphil cells: involved in energy production or storage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

PTH action when there is low blood Ca2+?

A

PTH increases plasma Ca++ and decreases plasma phosphate
Bone: Increases osteoclast number & activity to increase Ca++ resorption of bone
Kidney: Stimulates Ca2+ reabsorption in the distal tubule of the kidney, decreasing urine Ca2+ excretion
Liver: PTH acts to stimulate synthesis of 1, 25-(OH)2-vitamin D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How does phosphorous levels change in response to Ca2+?

A

See increased phosphate release due to PTH actions at the intestines and bone, but a net decrease in plasma levels due to the effects of PTH on the kidney

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How is PTH levels regulated?

A

The dominant regulator of PTH is plasma [Ca2+] and the secretion of PTH is inversely related to [Ca2+]

Low plasma Ca2+ concentrations stimulate PTH release
High plasma Ca2+ concentrations inhibit PTH release

no direct control of PTH with phosphate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is calcitonin?

A
  • Decreases plasma calcium levels by parafollicular cells (C cells) of the thyroid gland
  • Inhibits osteoclast motility and activity
  • Inhibits bone resoprtion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the function of vitamin D?

A
  1. Heterodimerizes with RXR (DNA recognition sequences)
  2. Support circulating calcium concentrations by calbindin and increased expression of calcium channels TRPV 5/6
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the main regulators of calcium concnetration into the interstitial space?

A

PMCA1b (Calcium active transporter) and NCX (the sodium calcium exchanger)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Deficiencies in Vitamin D?

A

Rickets, Osteomalacia, Osteoporosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How is Vitamin D synthesized?

A
  1. 7-dehydrocholesterol is photo converted in the skin by ultraviolet radiation to cholecalciferol or vitamin D3
  2. First hydroxylation occurs in liver to yield 25-hydroxycholecalciferol
  3. 25-hydroxycholecalciferol is transported to the kidney and through PTH stimulation, is hydroxylated to 1,25-dihydroxycholecalciferol (1,25-(OH)2D3; Calcitriol) which is the active and most potent metabolite of Vitamin D
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Role of Vitamin D in the bone?

A

Stimulates release of Ca by osteoblasts causing them to release RANKL activating osteoclasts promoting bone mineralization and regrowth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the cause of hypocalcemia? Sx?

A

Damage to parathyroid during thyroid surgery, vitamin D deficiency, or CKD
Sx: Progressive, Hyperexcitability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the cause of hypercalcemia? Sx?

A

Often due to tumor in PT gland
Sx: Depressed CNS and muscle, hypercalcemic crisis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the function of bone?

A
  1. Structural support
  2. Locomotion
  3. Protects vital organs
  4. Depot of ions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is cortical/compact bone?

A

Forms the dense outer shell of the adult skeleton

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is Trabecular or Cancellous Bone?

A

Spongy, honeycombed (20% of bone)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is diaphysis?

A

The shaft of a long bone containing medullary cavity of marrow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is epiphysis?

A

Ends of a long bone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is the epiphyseal plate?

A

Growth plate made of cartilage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
What is the periosteum?
Membrane that covers bone and the site of ligament and tendon attachment
26
What are the hormones associated with bone growth during youth?
**Infancy:** Epiphyseal plate activity is stimulated by growth hormone & IGF-1 **Puberty:** Testosterone and estrogen
27
What are the major cell types of bone?
**Osteoblasts:** Bone forming cells **Osteocytes:** Mature bone cells **Osteoclasts:** (bone resorption) Secrete acids and proteases that dissolve the bone matrix and stimulates binding of osteoblast-generated RANKL to the RANK surface receptor on osteoclasts
28
Describe bone formation?
1. Osteoblasts synthesize and extrude collagen 2. Collagen fibrils form arrays of an organic matrix called the osteoid 3. Formation of Hydroxyapatite Crystals: Ca10(PO4)6(OH)2 * Dependent on Vitamin D and regulated by PTH
29
What is the difference between resoption and remodeling?
**Resorption:** Destroys entire matrix of the bone and diminishes bone mass to extract calcium **Remodeling:** Endocrine signals to resting osteoblasts generate paracrine signals to osteoclasts and precursors
30
Describe the process of bone resorption and remodeling?
1. Parathyroid hormone (PTH), shear stress, and transforming growth factor-β (TGF-β) induce osteoblast precursors to express the osteoclast differentiation factor RANK-ligand (or RANKL) 1. RANKL binds to RANK, a receptor expressed on osteoclast precursors 1. The RANKL–RANK binding, together with other factors such as macrophage colony stimulating factor (M-CSF), cause osteoclast differentiation 2. As mature osteoclasts resorb bone, matrix-bound factors such as TGF-β, insulin-like growth factor-1 (IGF-1), other growth factors, and cytokines are released 3. These liberated factors stimulate osteoblast precursors to develop into mature osteoblasts, which begin to refill the resorption cavities excavated by the osteoclasts
31
What is osteoporosis?
Abnormal loss of bone, predisposing patient o increased risk of fractures * Decreased peak bone mass and accelerated bone loss
32
What is the cause of postmenopausal osteoporosis?
Estogen deficiency increases activation and prolongs maturation of osteoclasts increasing vertebral compression fractures and wrist fractures risk
33
What are the common RF of male osteoporosis?
1. Smoking 2. Low body weight 3. Age 4. GCC use 5. androgen deprivation therapy 6. Testosterone def
34
What increases risk of disability and death due to osteoporosis?
hip fractures
35
What are sx of osteoporosis?
Most patients are **asymptomatic**: 1. Pain 1. Immobility 1. Shortened stature 1. Fractures 1. Kyphosis 1. Lordosis
36
How do you diagnose osteoporosis?
Measurement of Bone Mineral Density (BMD) using dual energy X-ray absorptiometry (DEXA scan)
37
What is a Central and peripheral Skeletal BMD?
**Central:** Measures BMD at hip and/or spine **Peripheral:** Measures BMD at forearm, heel, and/or phalanges
38
What is the gold standard of osteoporosis diagnosis?
Central Dual-Energy X-ray Absorptiometry (DEXA) provides T-score and Z-score
39
What is a T and Z score?
T: compare your bone density with that of a young adult Z: compare your bone density with that of your peer group
40
Calcium carbonate requires an ____ environment?
Acidic therefore requires food for absorption
41
What is the active form of vit d? Daily recommended value?
Calcitriol: 600-800U
42
Who qualifies for osteopenia/osteoporosis tx?
Men and women: 1. Hip or vertebral fracture 2. T-score ≤ -2.5 at femoral neck, total hip or lumbar spine 3. Postmenopausal women and men age 50+ with osteopenia
43
What is first line for osteoporosis?
bisphosphonates
44
What is the MOA of bisphosphonates?
1. Binds to hydroxyapatite in bone 2. Decreases osteoclast activity and inhibits osteoclast proliferation and adherence 3. Decreases bone resorption **Net effect:** Osteoblasts form well-mineralized bone without opposition from osteoclasts
45
How should bisphosphonates be taken?
Low PO F therefore should never be administered with food
46
Describe the main chemical component of bisphosphonates?
Pyrophosphate compound
47
What are the types of bisphosphonates?
1. Alendronate (Fosamax) 1. Risedronate (Actonel) 1. Ibandronate (Boniva) 1. Zoledronate (Reclast, Zometa) 1. Etidronate (Didronel): off-label 1. Pamidronate (Aredia): off-label
48
Zoledronate | Brand, Form, Indication
**Reclast: IV** * Osteoporosis * Annual infusion for treatment of osteoporosis. * Biannual infusions for prevention of osteoporosis **Zometa: IV** * Bone metastases Reduces vertebral (70%), hip (41%), non-vertebral (25%) fractures
49
Alendronate | Brand, Form, Indication
Fosamax, Binosto: PO **Indication:** Osteoporosis * Treatment dose: 10 mg/day or 70 mg weekly * Prevention dose : 5 mg/day or 35 mg weekly
50
Risedronate | Brand, Form, Indication, Dosing
Actonel, Atelvia: PO **Indication:** Osteoporosis **Atelvia is taken once weekly, with water 30 minutes before breakfast**
51
Ibandronate | Brand, Form, Indication, Dosing
Boniva **Form:** PO (stand or sit for 1hr after ingestion) and IV infusion **Indication:** Treatment and prevention of osteoporosis
52
Pamidronate | Brand, Form, Indication
Aredia: IV **Indication:** Hypercalcemia of malignancy and bone cancer, Pagets
53
Etidronate | Brand, Indication
Didronel **Indication:** Pagets
54
What are the medical indicataions for IV BPs?
1. Bone metastasis 2. Cancer hypercalcemia
55
What is a potent inhibitor of osteoclast activity and provides a bone-specific treatment?
Zoledronic acid (Zometa)
56
Bisphosphonates | ADR, DDI, CI, Monitoring
**ADR:** 1. Upset stomach (inflammation and erosions) 2. Musculoskeletal joint pain 3. Bisphosphonate-related osteonecrosis of the jaw (BRONJ) **DDI:** Do not co-administer with ANY other medications **CI:** Hypocalcemia (correct before therapy) **Monitoring:** After 3-5 years a risk assessment should be performed (FDA Warning): may DC if at moderate risk
57
What are the counseling points for Bisphosphonates?
1. Must swallow whole; do not crush 2. Take first thing in the morning with 6-8 ounces of plain water ONLY before eating 3. Must sit/stand for at least 1 hour with **ibandronate** 4. Stop taking if develop painful swallowing, chest pain or bad heartburn that does not go away
58
What Bisphosphonate formulations can be used in patients with GI or PO intolerance?
IV ibandronate and zoledronate
59
What are the types of SERMS?
Raloxifene (Evista) Bazedoxifene + Conjugated estrogens (Duavee)
60
Raloxifene | Brand, MOA, Indication, PiT, ADR
Evista **MOA:** Estrogen agonist in bone and estrogen antagonist in uterus and breast tissue **Indication:** Prevention of osteoporosis in post-menopausal women **PiT:** Mostly used by those intolerant to bisphosphonates **ADR:** Increases the risk of thromboembolic events (stroke), hot flushes, leg cramps
61
Duavee | Class, Indication, PiT, BBW
Conjugated estrogens + Bazedoxifene (SERM) **Indication:** Prevention of osteoporosis after menopause **PiT:** Only for postmenopausal women who still have a uterus **BBW:** Increased risk of dementia in >65YO taking estrogen alone * Increased VTE and stroke
62
What are the monoclonal antibodies for osteoporosis?
Denosumab (Prolia) Romosozumab (Evenity)
63
Denosumab | Brand, MOA, Indication, CI
Prolia, Xgeva **MOA:** Human Monoclonal Antibody against RANK Ligand disrupting osteoclast differentiation and function **Indication:** Last resort and postmenopausal women with osteoporosis with high fracture risk **CI:** Hypocalcemia
64
Describe the Wnt / β-Catenin Signalling Pathway?
1. FZD and co-receptor (LRP5/6) 2. Wnt activates its signaling pathway leading to β-catenin stimulated gene expression 3. Bone formation and protein synthesis occurs
65
What is the regulatory pathway of Wnt / β-Catenin Signalling Pathway?
Sclerostin: secreted by osteocytes which inhibits bone formation (antagonist_
66
How does sclerostin inhibit the pathway?
1. The chaperone LRP4 presents sclerostin to the Wnt co-receptors LRP5/6, facilitating sclerostin inhibition of Wnt/β-catenin signaling 2. β-catenin is phosphorylated and then targeted for degradation
67
Romosozumab | Brand, MOA, Onset
Evenity **MOA:** * **Inhibition of Sclerostin** increases bone formation by promoting survival and proliferation of osteoblasts through increased RANKL effects on osteoblasts * Inhibits the increase in **RANKL dependant** increases in osteoclast activity, reducing bone resorption **Onset:** Bone forming effect wanes after 12 doses **BBW:** Increase the risk of MI, stroke, and CV death **CI:** CV RF, hypocalcemia **ADR:** joint pain, headache, and pain at the site of injection
68
HRT | Indication, MOA, PiT
**Indication:** Prevention of postmenopausal osteoporosis **MOA:** 1. Decreases bone resorption 2. Increases Calcitrol concentrations 3. Increases intestinal calcium absorption 4. Preserves cortical and trabecular bone **PiT:** Not recommended for routine use due to increased cancer risk
69
Calcitonin | Brand, MOA, PiT
Miacalcin, Fortical, Calcimar **MOA:** Endogenous hormone released from the C-Cells of the thyroid when serum calcium levels are elevated, inhibiting osteoclastic bone resorption **PiT:** Treatment of osteoporosis in women at **least 5 years** post menopausal with **low bone mass and after other medications have failed**
70
What are the types of bone formation therapies?
Teriparatide (Forteo) ABALOPARATIDE (Tymlos)
71
Teriparatide | Brand, Class, MOA,
Forteo **Class:** rHPTH **MOA:** Stimulates bone formation by increasing osteoblast number and activity, and depresses osteoclast formation **Efficacy:** **If and when treatment is stopped,** bone density loss can be rapid and alternative agents should be considered to maintain BMD **BBW:** Osteosarcoma **CI:** Pagets, Radiation, osteoporosis prevention
72
Abaloparatide | Brand, Class, MOA, Warning, ADR
Tymlos **Class:** sPTHrP analog (PTH-related protein) **MOA:** Stimulates bone formation by the selective activation of PTH-1R **ADR:** Greater BMD increase and less hypercalcemia than teriparatide, osteosarcoma **Warning:** Do not use more than 2 years